Io Biotech (IOBT)

IOBT

0.96

High/Low: 0.98 / 0.96 Chg/Chg%: -0.02 / -2.03% Volume: 6638
Technical Analysis Historical Data Financials News & Analysis

IOBT NEWS

IO Biotech (IOBT) Expected to Announce Quarterly Earnings on Tuesday By MarketBeat - 3 days ago

IO Biotech (NASDAQ:IOBT – Get Free Report) is expected to announce its Q1 2025 earnings results before the market opens on Tuesday, May 13th. Analysts expect the company to announce earnings of ($0.4… [+1588 chars]...

Read more
XTX Topco Ltd Makes New $26,000 Investment in IO Biotech, Inc. (NASDAQ:IOBT) By MarketBeat - 1 week ago

XTX Topco Ltd bought a new stake in shares of IO Biotech, Inc. (NASDAQ:IOBT – Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities & … [+2575 chars]...

Read more
IO Biotech Showcases Scientific Leadership Through Cancer Vaccines Educational Session at the American Association for Cancer Research (AACR) Annual Meeting 2025 By IO - 2 weeks ago

NEW YORK, April 26, 2025 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulatory, off-the-shelf therapeutic cancer vaccines, toda… [+4593 chars]...

Read more
IO Biotech Presents New Data at AACR 2025 Supporting Dual Mechanism and Immune Activation of Cancer Vaccines IO102-IO103 and IO170 By IO - 2 weeks ago

Preclinical data further support the potential of dual-antigen and TGF--directed vaccines to reshape the tumor microenvironment and drive anti-tumor immunity NEW YORK, April 25, 2025 (GLOBE NEWSWIRE… [+5056 chars]...

Read more
Top Stock
CurrencyPrice Chg
BA 		206.33 1.61
0.79%
CVX 		140.45 -1.22
-0.86%
CAT 		349.49 -0.17
-0.05%
INTC 		21.37 -0.16
-0.72%
MSFT 		453.05 0.94
0.21%
DIS 		111.81 -1.13
-1%
DOW 		29.54 -0.63
-2.09%
CSCO 		65.51 4.22
6.89%
GS 		613.98 2.38
0.39%